THE NATIONAL BLEEDING DISORDERS FOUNDATION (FORMERLY THE NATIONAL HEMOPHILIA FOUNDATION) IS DEDICATED TO FINDING CURES FOR INHERITABLE BLOOD AND BLEEDING DISORDERS AND TO ADDRESSING AND PREVENTING THE COMPLICATIONS OF THESE DISORDERS THROUGH RESEARCH, EDUCATION, AND ADVOCACY ENABLING PEOPLE AND FAMILIES TO THRIVE.
Executive compensation, broken down
Form 990 · Schedule J · 10 reported individuals · Filing year 2024
- Base
- $371k
- Bonus
- $25k
- Other
- $3k
- Benefits
- $360
- Base
- $303k
- Bonus
- $28k
- Other
- $2k
- Benefits
- $17k
- Base
- $303k
- Bonus
- —
- Other
- $3k
- Benefits
- $24k
- Base
- $212k
- Bonus
- —
- Other
- $3k
- Benefits
- $52k
- Base
- $217k
- Bonus
- —
- Other
- $3k
- Benefits
- $25k
- Base
- $175k
- Bonus
- —
- Other
- $1k
- Benefits
- $52k
- Base
- $175k
- Bonus
- —
- Other
- $420
- Benefits
- $36k
- Base
- $178k
- Bonus
- —
- Other
- $630
- Benefits
- $29k
- Base
- $205k
- Bonus
- —
- Other
- $690
- Benefits
- $360
- Base
- $98k
- Bonus
- $37k
- Other
- $739
- Benefits
- $6k
| Position | Base | Bonus | Other | Benefits | Total |
|---|---|---|---|---|---|
Chief Scientific Officer key employee | $371k | $25k | $3k | $360 | $415k $449k |
President & CEO | $303k | $28k | $2k | $17k | $350k $379k |
Managing Director highest compensated employee | $303k | — | $3k | $24k | $349k $377k |
Chief Business Officer officer (unspecified) | $212k | — | $3k | $52k | $291k $314k |
Chief Operating Officer | $217k | — | $3k | $25k | $276k $299k |
Venture Principal highest compensated employee | $175k | — | $1k | $52k | $247k $267k |
S.v.p. of Public Policy highest compensated employee | $175k | — | $420 | $36k | $237k $256k |
Access & Strategic Innovation highest compensated employee | $178k | — | $630 | $29k | $225k $243k |
Senior Development Director | $205k | — | $690 | $360 | $210k $227k |
President & CEO - Thru 3/31/24 | $98k | $37k | $739 | $6k | $151k $163k |
Teal figures restate each filed amount in 2026 dollars.
Estimated with New York-Newark-Jersey City, NY-NJ-PA metro-area CPI-U, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.
Plus 13 unpaid individuals.
Down 1%
from 2023
From $420k in 2023 to $415k in 2024.
Estimated with New York-Newark-Jersey City, NY-NJ-PA metro-area CPI-U, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.
Revenue and expenses over time
NATIONAL BLEEDING DISORDERS FOUNDATION reported revenue and expenses across 2 filing years.
Compare any role, sector, or revenue band
Build your own benchmark from millions of reported positions.